0.15Open0.20Pre Close1 Volume62 Open Interest72.00Strike Price15.00Turnover52.75%IV6.83%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.0843Delta0.0406Gamma616.96Leverage Ratio-0.0833Theta-0.0006Rho-52.04Eff Leverage0.0112Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet